Navigation Links
SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the World's First Prototype for its Next Generation Application for Drug Safety Administration
Date:12/5/2012

JERUSALEM, December 5, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC)(the "Company"), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, is pleased to announced it has identified and is commencing to develop the world's first prototype for its next generation application for Drug Safety Administration. The prototype development and the technology application is expected to be completed within 4-6 months and will be then demonstrated to worldwide major drug container manufacturers for possible adoption to ensure a new generation drug administration safety application.

The Company recently launched its new website which has also been optimized for accessibility and easy navigation on smartphones and tablets as well as laptops and home computers.  

In conjunction with the website unveiling, the Company has published a new video demonstrating the SafeCode voice-activation technology as a novel product candidate for the medical industry.  Investors are encouraged to view the video on the Company's website or on YouTube at http://www.youtube.com/watch?v=PEy9ygT6jaA.

Across the past month, the Company has been granted eligibility status by the Depository Trust Company and commenced trading on the OTC Bulletin Boards.

"We are dedicated to providing a high-quality product and transparency to our stakeholders. We are taking all necessary steps to meet these corporate goals and doing so in an expeditious manner," said Joel Klopfer, Chief Executive Officer at SafeCode Drug Technologies Corp.  "Accidental deaths resulting from administering incorrect medication represent a multi-billion-dollar area of unmet need.  We believe that we have a solution with our patent-pending voice-recognition technology that will benefit manufacturers, pharmacists and patients while building our corporate value.  This is an exciting time for our company and shareholders as we enter the commercialization phase.  The new website was important to us as it showcases the SafeCode solution while giving investors fast, user-friendly access to information on our company."

About SafeCode Drug Technologies

SafeCode Drug Technologies Corporation is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov

Contact:
Joel Klopfer
Joel.Klofer1@gmail.com
+9722-5021322

 



'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
2. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
3. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
4. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
5. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
6. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
7. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
8. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
9. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
10. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
11. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
Breaking Medicine Technology:
(Date:10/13/2017)... Fort Worth, TX (PRWEB) , ... October 13, ... ... and financial planning agency serving communities in the greater Dallas, Miami, and Raleigh ... a young boy fighting to overcome a rare and deadly chromosome abnormality. , ...
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
Breaking Medicine News(10 mins):